A carregar...
Publicação
Navigating transformative technology: how Pfizer and Biontech´s alliance reflects the build, borrow, buy strategy
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.9 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This paper presents a case study on Pfizer from 2013 to 2023, examining the restructurings
under the CEOs Ian Read and Albert Bourla, including Bourla’s focus on innovative
pharmaceuticals and the debate of the costs and benefits of streamlining operations against
those of diversification, within the pharmaceutical industry’s dynamic competitive landscape.
It also analyses Pfizer’s strategic shift to mRNA technology through its BioNTech partnership,
specifically in developing the first COVID-19 vaccine, using the Resource Pathways
framework.
Descrição
Palavras-chave
Pharmaceutical industry Corporate strategy Innovator´s dilemma Build Borrow Buy Strategic alliance Pfizer Biontech